Reported 1 day ago
TD Cowen has raised the price target for Tempus AI (NASDAQ:TEM) from $62 to $72, maintaining a 'Buy' rating, impressed by the company's significant growth in genomic volumes and positive outlook in its Ambry business. Tempus AI reported revenues of $314.6 million in Q2, exceeding expectations, and demonstrated improved performance in its genomic segment. Despite acknowledging the investment potential in TEM, the article suggests some AI stocks may present better opportunities.
Source: YAHOO